This Is What Whales Are Betting On Pfizer - Pfizer (NYSE:PFE)

Core Insights - Investors are showing a bullish stance on Pfizer, with significant options trading activity indicating potential upcoming developments [1] - The sentiment among large traders is mixed, with 52% bullish and 35% bearish positions observed [2] - The price target for Pfizer is estimated to be between $20.0 and $30.0 based on recent options activity [3] Options Trading Analysis - A total of 17 uncommon options trades for Pfizer were identified, with 6 puts totaling $1,032,603 and 11 calls totaling $981,258 [2] - The volume and open interest data for Pfizer's options provide insights into liquidity and trader interest within the $20.0 to $30.0 strike price range over the past 30 days [4] Company Overview - Pfizer is one of the largest pharmaceutical companies globally, generating approximately $60 billion in annual sales, primarily from prescription drugs and vaccines [10] - Key products include the pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis, with international sales accounting for 40% of total revenue [10] Market Standing - Recent analyst ratings suggest a neutral outlook for Pfizer, with an average target price of $30.0 from one expert [12] - Current trading volume for Pfizer is reported at 22,909,967, with the stock price at $27.0, reflecting a decrease of 1.36% [15]